Overview

Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment

Status:
Completed

Trial end date:
2009-05-26

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy, safety and tolerability of donepezil in children with persistent attention impairment that is present at least 12 months after the completion of cancer treatment.

Phase:

Phase 3

Details

Lead Sponsor:

Eisai Inc.

Collaborator:

Eisai Limited

Treatments:

Donepezil